Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations comprising hydralazine, prazosin, torsemide, spironolactone, and/or naltrexone and treatments using same

Formulations comprising hydralazine, prazosin, torsemide, spironolactone, and/or naltrexone and treatments using same

US Patent 11737985 · Granted Aug 29, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulations comprising aldosterone receptor antagonists and treatments using sa2021
Fast multi-width instruction issue in parallel slice processor2021
Propagating constants of structured soft blocks while preserving the relative pl2020
Operation of a multi-slice processor implementing load-hit-store handling2020
Merging status and control data in a reservation station2020
Methods of treatment comprising torsemide2020
Treatments and formulations comprising Torsemide2019
Broadcasting messages between execution slices for issued instructions indicatin2019
Controlled-release formulations comprising Torsemide2018
Fast multi-width instruction issue in parallel slice processor2018
Operation of a multi-slice processor implementing a mechanism to overcome a syst2018
Fast multi-width instruction issue in parallel slice processor2018